Novozymes A/S
General ticker "NVZMF" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $28.5B (TTM average)
Novozymes A/S does not follow the US Stock Market performance with the rate: -30.4%.
Estimated limits based on current volatility of 1.4%: low 58.22$, high 59.87$
Factors to consider:
- Company pays dividends (annually): last record date 2026-03-25, amount 0.66$ (Y1.12%)
- Price in estimated range
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [46.19$, 66.49$]
- 2025-12-31 to 2026-12-31 estimated range: [47.50$, 68.08$]
Financial Metrics affecting the NVZMF estimates:
- Negative: with PPE of 70.8 at the end of fiscal year the price was very high
- Positive: 7.54 < Operating profit margin, % of 13.07
- Positive: Return on assets ratio (scaled to [-100,100]) of 13.05 > 6.06
- Positive: 2.88 < Industry operating profit margin (median), % of 5.52
- Positive: Investing cash flow per share per price, % of -0.11 > -0.60
- Negative: Industry earnings per price (median), % of 2.23 <= 4.45
- Negative: 0.01 < Interest expense per share per price, % of 0.04
- Negative: Shareholder equity ratio, % of 73.55 > 64.29
Short-term NVZMF quotes
Long-term NVZMF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | DKK17,553.00MM | DKK17,905.94MM | DKK3,830.79MM |
| Operating Expenses | DKK12,992.00MM | DKK13,928.50MM | DKK3,330.14MM |
| Operating Income | DKK4,561.00MM | DKK3,977.44MM | DKK500.65MM |
| Non-Operating Income | DKK-5.00MM | DKK-66.34MM | DKK-83.84MM |
| Interest Expense | DKK102.00MM | DKK23.24MM | DKK76.40MM |
| R&D Expense | DKK2,001.00MM | DKK2,017.79MM | DKK412.91MM |
| Income(Loss) | DKK4,556.00MM | DKK3,911.10MM | DKK416.80MM |
| Taxes | DKK870.00MM | DKK870.62MM | DKK111.22MM |
| Net Income(Loss)* | DKK3,676.00MM | DKK3,025.57MM | DKK305.37MM |
| Stockholders Equity | DKK13,837.00MM | DKK13,978.00MM | DKK11,176.00MM |
| Inventory | DKK3,772.92MM | DKK3,627.00MM | DKK720.60MM |
| Assets | DKK27,983.00MM | DKK28,391.00MM | DKK15,195.60MM |
| Operating Cash Flow | DKK4,006.00MM | DKK4,152.00MM | DKK1,019.90MM |
| Capital expenditure | DKK2,890.00MM | DKK2,056.00MM | DKK359.80MM |
| Investing Cash Flow | DKK-2,672.00MM | DKK-2,133.00MM | DKK-199.70MM |
| Financing Cash Flow | DKK-1,250.00MM | DKK-1,889.00MM | DKK-703.20MM |
| Earnings Per Share** | DKK13.19 | DKK10.89 | DKK0.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.